期刊文献+

甲银屑病与英夫利西单抗

原文传递
导出
摘要 指(趾)甲病变是银屑病最常见的临床表现之一。随着人们生活水平的提高和社会交往的增多,甲银屑病因为其凸显的发病部位而受到患者的重视,继而产生社会心理压力。甲银屑病的治疗也因其与银屑病性关节炎(psoriaticarthritis,PsA)关系密切而受到医生和患者的关注和重视。
作者 孙彩虹 顾恒
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2013年第3期219-221,共3页 Chinese Journal of Dermatology
  • 相关文献

参考文献25

  • 1Reich K. Approach to managing patients with nail psoriasis. JEur Acad Dermatol Venereol, 2009, 23 Suppl 1: 15-21.
  • 2Lawry M. Biological therapy and nail psoriasis. Dermatol Ther,2007, 20(1): 60-67.
  • 3Maejima H, Taniguchi T, Watarai A, et al. Evaluation of naildisease in psoriatic arthritis by using a modified nail psoriasisseverity score index. Int J Dermatol, 2010,49(8): 901-906.
  • 4Olivieri I,D'Angelo S, Palazzi C, et al. Treatment strategies forearly psoriatic arthritis. Expert Opin Pharmacother, 2009, 10(2):271-282.
  • 5Rich P, Griffiths CE, Reich K, et al. Baseline nail disease inpatients with moderate to severe psoriasis and response to treat-ment with infliximab during 1 year. J Am Acad Dermatol, 2008,58(2): 224-231.
  • 6Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool forevaluation of nail psoriasis. J Am Acad Dermatol, 2003,49(2):206-212.
  • 7Noiles K, Vender R. Nail psoriasis and biologies, J Cutan MedSurg, 2009, 13(1): 1-5.
  • 8Fantuzzi F, Del Giglio M, Gisondi P, et al. Targeting tumornecrosis factor alpha in psoriasis and psoriatic arthritis. ExpertOpin Ther Targets, 2008, 12(9): 1085-1096.
  • 9Reich K,Nestle FO, Papp K, et al. Infliximab induction andmaintenance therapy for moderate-to-severe psoriasis: a phaseIII, multicentre, double-blind trial. Lancet, 2005, 366(9494):1367-1374.
  • 10Rigopoulos D, Gregoriou S, Stratigos A, et al. Evaluation of theefficacy and safety of infliximab on psoriatic nails: an unblinded,nonrandomized, open-label study. Br J Dermatol, 2008, 159(2):453-456.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部